InChIKey	OIRDTQYFTABQOQ-KQYNXXCUSA-N
Compound Name	Adenosine
Canonical SMILES	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	6.78
Source	ChEMBL;BindingDB

DrugBank ID	DB00640
Drug Name	Adenosine
CAS Number	58-61-7
Groups	approved investigational
ATC Codes	C01EB10
Description	The structure of adenosine was first described in 1931,[A229823] though the vasodilating effects were not described in literature until the 1940s.[A229828] Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy,[L31983] though it is rarely used in this indication, ...

---

Categories: Adenosine, antagonists & inhibitors Agents producing tachycardia Alkenes Analgesics Antiarrhythmic agents Antiarrhythmics, Class V Biological Factors Carbohydrates Cardiac Therapy Cardiovascular Agents Central Nervous System Agents Cyclohexanes Cyclohexenes Cycloparaffins Glycosides Heterocyclic Compounds, Fused-Ring Hydrocarbons, Acyclic Miscellaneous Cardiac Drugs Miscellaneous Therapeutic Agents Moderate Risk QTc-Prolonging Agents Neurotransmitter Agents Nucleic Acids, Nucleotides, and Nucleosides Nucleosides Peripheral Nervous System Agents Polyenes Purine Nucleosides Purinergic Agents Purinergic Agonists Purinergic P1 Receptor Agonists Purines QTc Prolonging Agents Ribonucleosides Sensory System Agents Terpenes Vasodilating Agents

---

Cross-references: BindingDB: 14487 ChEBI: 16335 CHEMBL477 ChemSpider: 54923 Drugs Product Database (DPD): 4732 C00212 D00045 PDB: ADN PharmGKB: PA448049 PubChem:60961 PubChem:46508728 RxCUI: 296 Therapeutic Targets Database: DAP000223 Wikipedia: Adenosine ZINC: ZINC000002169830